• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    More On DIVISLAB.BO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Divi's Laboratories Limited (DIVISLAB.BO)

    -BSE
    1,742.45 Down 22.90(1.30%) Jan 30, 5:11AM EST
    Add to Portfolio
    Prev Close:1,765.35
    Open:1,787.50
    Bid:1,750.00
    Ask:1,742.45
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:1,713.00 - 1,790.00
    52wk Range:1,217.00 - 1,881.90
    Volume:9,656
    Avg Vol (3m):12,777
    Market Cap:231.28B
    P/E (ttm):29.91
    EPS (ttm):58.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Headlines

    • No Headlines available for DIVISLAB.BO at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Divi’s Laboratories Limited manufactures and sells active pharmaceutical ingredients (API) and intermediates for generics in India. The company also offers building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betac... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback